Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Long Term Debt 2022–2025
Axsome Therapeutics, Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Axsome Therapeutics, Inc. long term debt as of December 31, 2025: 117.7M, a 34.84% decrease year-over-year.
- Axsome Therapeutics, Inc. long term debt for 2025 were 117.7M, a 34.84% decrease from 2024.
- Axsome Therapeutics, Inc. long term debt for 2024 were 180.7M, a 1.48% increase from 2023.
- Axsome Therapeutics, Inc. long term debt for 2023 were 178.1M, a 88.92% increase from 2022.
- Axsome Therapeutics, Inc. long term debt for 2022 were 94.3M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Axsome Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $118 |
| 2024 | $181 |
| 2023 | $178 |
| 2022 | $94 |
Axsome Therapeutics, Inc. Long Term Debt — FAQ
Axsome Therapeutics, Inc. (AXSM) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's long term debt history?
The chart and table above show Axsome Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.